Home > News

News

Clinical Considerations for Contraception During COVID: Extended Duration of IUDs and Implants

During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.

5 Pearls from the 2020 States Forum on Pharmacist Birth Control Services

The second annual States Forum on Pharmacist Birth Control Services recently was held by the Birth Control Pharmacist project in partnership with the National Alliance of State Pharmacy Associations (NASPA).…

Contraception During COVID: California’s Medi-Cal and FamilyPACT Programs Cover Depo-SubQ Provera

We recently wrote about the importance of offering patients subcutaneous depot medroxyprogesterone acetate (DMPA-SQ) as a contactless form of contraception during the COVID-19 public health emergency. California pharmacists can prescribe…

Clinical Considerations for Contraception During COVID: Patient Self-Administration

During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.

2020 CDC Update for Contraceptive Use in Women at High Risk for HIV

The CDC published updated guidelines to the 2016 U.S. Medical Eligibility Criteria for Contraceptive Use regarding women at high risk for HIV infection in April 2020.

Twirla: A New Contraceptive Patch

Twirla is a new contraceptive patch that was approved by the FDA earlier this month on February 14, 2020.

New Report Released on State Efforts to Expand Access to Contraception in Pharmacies

Download free 17-page report describing the current landscape of direct access to contraception in pharmacies, state legislative approaches and experiences, as well as implementation.

New APhA-ASP Women’s Health Campaign

New APhA-ASP Women’s Health Campaign Kick Off Event at University of Michigan College of Pharmacy

Interactions Between Emergency Contraception and Other Hormonal Contraceptives

The American Society for Emergency Contraception (ASEC) recently held their annual EC Jamboree in Washington, DC. Participants included health care providers, researchers, reproductive health advocates, and pharmaceutical stakeholders. One highlight…

5 Pearls from the States Forum on Pharmacist Birth Control Services

The inaugural States Forum on Pharmacist Birth Control Services was recently held in conjunction with the American Pharmacists Association (APhA) 2019 Annual Meeting in Seattle, Washington. This session was hosted by Birth…